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ABstrACt: With the enactment of comprehensive health reform, reimbursement for a 
variety of health care services will likely depend on evidence to support that provision. 
Understanding what constitutes “evidence” will have a profound effect on the range of 
clinical care provided. A too-narrow definition may have a considerable impact on pediat-
ric care in particular: much of current child health care requires consideration of a broader 
body of evidence than is usually relied upon when developing clinical guidelines. This is 
especially true for care that addresses behavioral and developmental problems. The current 
standard for evaluating evidence uses study design as a proxy for the quality of evidence; 
it may therefore inadvertently exclude many important findings and fail to support further 
relevant research. The project described here yielded a new, broader framework for evalu-
ating clinical practice, one that should be of value to both clinicians and policymakers. 
                    
OvErviEW
Over the past two decades, pediatric clinical practice in the United States has 
shifted from a predominant focus on disease and infection to one of health pro-
motion and risk reduction. As a result of technological advances and new under-
standings in early human development,1 child health promotion now underlies 
much of children’s medical care.2 In the U.S., major threats to children’s health 
and well-being range from injury and abuse to obesity, developmental disability, 
and illicit drug use. Despite these substantial changes in childhood morbidity and 
its treatment, the tools used to gather evidence and measure the effects of health 
care interventions have not kept pace. Thus, the evidence supporting new, effec-
tive public-health-based approaches to child health promotion has not been given 
sufficient weight in the formulation of guidelines for care and reimbursement. 
Unless the existing evidence framework is modernized and broadened, 
health care reform efforts that promote evidence-based care may inadvertently 
limit the use of effective interventions and may undermine advances in child 
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health and health care, to the detriment of America’s 
children. 
Evidence-based medical care as we know it 
today came into being during the last decades of the 
20th century as a method of evaluating the effects 
of short-term treatments for individual patients. The 
research and analytic techniques developed then have 
dramatically improved many areas of health care, from 
antibiotics for common infections to chemotherapy 
for difficult-to-treat cancers. By contrast, many child 
health promotion interventions do not involve medical 
treatment, per se, but aim to change the physical, social 
or emotional environment in which children live and 
learn. The effects of these changes may only become 
apparent many years in the future. As a result, child 
health promotion within pediatric medicine is consid-
ered evidence-informed, rather than fully evidence-
driven.3 This issue brief describes a new framework for 
evaluating health care interventions that better suits the 
goals and methods of modern child health care.
EvidEnCE-BAsEd MEdiCinE in COntExt
The field of pediatrics began with specialized clinical 
services and research focused primarily on the care of 
newborn infants and on the prevention and treatment 
of childhood infections. These issues lent themselves 
well to study through the use of randomized controlled 
trials (RCTs). RCTs are designed to optimize causal 
inference for therapies directed at individual patients 
through scrupulous selection of subjects and carefully 
controlled experimental conditions. Owing in part to 
the tremendous advances that RCT has facilitated, 
these older threats to child health have receded in 
importance in the United States and other economically 
developed nations. Now, insults related to children’s 
cognitive, social, and emotional development such 
as accidental injury, abuse, drug abuse, obesity, poor 
housing, and substandard education endanger more 
children than do infectious diseases. These conditions 
develop through complex interactions between biology 
and exposure to the physical and social environment,4 
interactions that are not readily amenable to study 
through controlled interventions. 
Today, health care is one of a number of factors 
that affect children’s outcomes. Reflecting on the mul-
tifactorial determinants of children’s health and well-
being, a 2004 Institute of Medicine (IOM) report rede-
fined child health as “the extent to which individual 
children or groups of children are able or enabled to 
develop and realize their potential; satisfy their needs; 
and develop the capacities to allow them to interact 
successfully with their biological, physical, and social 
environments.”5
The breadth of this definition significantly 
expands both the potential inputs into children’s health 
as well as its potential outcomes. It creates substantial 
challenges in demonstrating the relationships between 
them. There is an emerging consensus that RCTs 
cannot easily test the complex relationships implicit 
in most clinical interventions designed to promote 
health.6 And the cost and complexity of RCTs aimed at 
investigating typical children’s health promotion inter-
ventions are complicated by these factors:
Many child health promotion interventions are •	
directed at the sites upon which children, by 
their very nature, are dependent: families, com-
munities and schools. Evaluating the effective-
ness of these indirect interventions through 
classical RCTs requires dramatically increased 
numbers of research subjects and substantially 
increased trial costs.
The effects of interventions on children are •	
frequently realized years later. This not only 
inflates the complexity and cost of research, 
but also risks rendering a study irrelevant by 
the time it is completed, as the conditions under 
study may have changed in the intervening 
decades.
Childhood is characterized by change; singling •	
out specific changes resulting from interven-
tions can become a difficult task. Consequently, 
studies measuring dynamic effects in childhood 
require careful and complex assessments, and 
generally larger numbers of research subjects.
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Properly conducted RCTs require that subjects •	
be as similar as possible, and receive precisely 
the same treatments. These same characteris-
tics—homogeneous subjects, tightly controlled 
procedures, and additional resources provided to 
the clinical setting—may make the study results 
difficult to apply outside of a research setting. 
These technical issues, combined with resource 
scarcity, have resulted in the successful completion of 
only relatively few high-quality randomized controlled 
trials of child health promotion in the clinical context. 
The United States Preventive Services Task Force 
(USPSTF), which is charged by the Department of 
Health and Human Services to make recommendations 
about preventive services that should be incorporated 
routinely into primary medical care, uses a transparent 
approach to assessing scientific evidence of effective-
ness. Their published methods favor randomized trials. 
In fact, many of their intervention and outcome analy-
ses include only evidence derived from RCTs.
As a result, the USPSTF has found insufficient 
evidence to recommend well-accepted components of 
child health promotion. The absence of USPSTF guide-
lines in many areas of child health has led children’s 
health professionals determined to provide high qual-
ity, comprehensive preventive care to rely upon recom-
mendations from the American Academy of Pediatrics 
(AAP). The AAP recommendations are derived from 
expert consensus based on more extensive sources 
of data and less rigorous standards. The AAP and the 
USPSTF have different missions and the advice they 
offer sometimes appears to conflict, as illustrated in 
Exhibit 1. 
Given the practical limitations of applying 
RCTs to evaluate much of child health care, alternative 
approaches to obtaining, assembling, and evaluating 
scientific evidence are needed in order to promote the 
evidence-based practice of pediatrics. This issue brief 
describes the process and results of a collaborative 
effort to organize and evaluate new evidence standards 
for child health promotion. An organizing framework 
was collaboratively developed by a multidisciplinary 
group of leading practitioners, researchers, and policy-
makers through an iterative, inclusive, consensus pro-
cess that took place over the course of two years. 
EngAging tHOugHt LEAdErs in 
rEACHing COnsEnsus
This process began with an assessment of the literature 
available for guiding decisions in two key areas that 
had been reviewed by the USPSTF in 2005: obesity 
prevention and early childhood developmental assess-
ment and intervention. In conducting our own broad 
review of the literature, we found 1,036 abstracts on 
obesity screening. Of those, only 18 were carried out in 
primary care settings and only one was an RCT; most 
described processes of care. Similarly among the 942 
Exhibit 1. Comparison of Recommendations for Childhood Screening from the  
American Academy of Pediatrics (AAP) and the U.S. Preventive Services Task Force (USPSTF)
AAP/Bright Futures USPSTF
Newborn hearing Recommended (2008)
Child abuse and domestic violence Insufficient evidence to recommend
Adolescent alcohol use Insufficient evidence to recommend
Overweight Insufficient evidence to recommend (revised to “B” in 2009)
Development in children under 5 years old Insufficient evidence to recommend
Elevated blood lead level Insufficient evidence to recommend
Note: The two organizations have different missions: the AAP seeks to provide comprehensive guidelines for clinical preventive care; the USPSTF reviews the published evidence 
for selected prevention activities, and considers health promotion for all ages.  
Sources: American Academy of Pediatrics, Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents, 3rd Edition (Elk Grove Village, Ill.: AAP, 2007); 
and United States Preventive Services Task Force.
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abstracts for screening related to child development, 
growth and development, as well as child behavior and 
related topics, only one RCT was done in a primary 
care setting, and almost all outcomes were related to 
process measures. 
Based on this work, a small, interview-based 
survey was designed and administered to 11 leading 
child health care researchers to assess their opinions 
regarding evidence-for-practice decisions. Exhibit 2 
presents the survey results obtained at the initiation 
of the interview. In general, the respondents endorsed 
basing practice recommendations on a variety of fac-
tors and evidence, and tended to disagree with limiting 
evidence to that generated by RCTs.
There was general agreement that recommenda-
tions for preventive child health care could be based on 
a variety of expertise and evidence. However, to better 
examine the issues related to which questions called 
Exhibit 2. Baseline Opinions Regarding Evidence-for-Practice Decisions
Statement
Mean Rating
(n=11)
The only important factor to consider when making a clinical practice decision is evidence  
of effectiveness.
2.36
Evidence of effectiveness is only one of a number of factors to consider when making a 
clinical practice decision.
4.55
Clinical practice decisions are based on many considerations. Evidence of effectiveness is 
only one factor and frequently it is not the most important.
2.45
With respect to evidence, clinical practice decisions should be based on the best evidence 
available.
4.82
Among types of evidence, when available, RCTs provide the strongest experimental 
evidence of causality.
4.00
RCTs should be the standard against which all research designs should be measured. 2.91
Anything short of an RCT is inadequate for making a truly informed decision. 1.73
1= Strongly disagree   2= Disagree   3= Neither agree/disagree   4= Agree   5= Strongly agree. 
Source: Authors’ original data.
Exhibit 3. Papers Commissioned and Presented for Year II Consensus Conference
Title Author/s
Overview, History and Charge: Putting Our Discussion in Context Robert D. Sege 
Sufficiency of Evidence: When Is It Enough?i Barbara Yawn
Child Health Promotion Interventions: Use of Decision Analysis to Determine  
When Further Study Is Worthwhileii
Peter Neumann,
Joshua Cohen 
e-Delphi Results: Developing Evidence Standards for Child Health Promotion Edward De Vos
Pediatric Preventive Services Assessment: Outcome Trajectory Thomas Dewitt
Evidence Standards for Child Health Promotion: Community Level Outcomesiii Neal Halfon
Evidence Synthesis Virginia Moyer
i B. Yawn, “Sufficiency of Evidence: When Is It Enough?” Paper presented at “Proceedings of the Development of Evidence Standards for Child Health Promotion: Preparing the 
Meal Conference (Rockville, Md.: 2007). 
ii J. T. Cohen and P. J. Neumann, “Using Decision Analysis to Better Evaluate Pediatric Clinical Guidelines,” Health Affairs, Sept./Oct. 2008 27(5):1467–75. 
iii N. Halfon and M. Hochstein, “Life Course Health Development: An Integrated Framework for Developing Health, Policy, and Research,” Milbank Quarterly, 2002 80(3):433–79.
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for which types of evidence, we enlisted the participa-
tion of a group of leaders in child health policy and 
practice. These included leadership from the American 
Academy of Pediatrics’ Bright Futures initiative, mem-
bers of the USPSTF, researchers involved in evidence-
based reviews and policy, and individuals drawn from 
private and federal funding agencies. After a process 
that included interviews, structured working group 
meetings, as well as the examination of commissioned 
manuscripts and Internet-based electronic Delphi pro-
cesses, the group moved from examining areas about 
which there was broad agreement and disagreement to 
the development of a new framework for understand-
ing evidence in the field of child health promotion. A 
meeting of the participants was held in 2007 to further 
clarify the issues that are unique to child health promo-
tion and to consider a framework to organize evidence 
for practice. Exhibit 3 presents topics considered at that 
meeting.
uniquE COnsidErAtiOns guiding 
EvidEnCE stAndArds
At the core of the controversy concerning child health 
promotion in clinical care are two basic questions: 
What types of outcomes are the interventions •	
under consideration designed to deliver? 
Based on risks and benefits, how certain would •	
we need to be to make policies for implementa-
tion or reimbursement?
To address these questions, two types of factors 
that are extraordinarily important during childhood 
must be considered: 1) factors affecting the child’s 
developmental trajectory, and, 2) factors related to the 
social ecology of childhood—that is, the social context 
that shapes children’s health and the course of their 
development.
Children naturally progress through predictable 
developmental stages, marked by physical, emotional, 
social, and cognitive changes. The trajectory of their 
development, its rate and ultimate success in terms of 
adult health and functioning are influenced by a variety 
of intrinsic biological and extrinsic environmental fac-
tors. These factors may be potentially damaging to 
the child’s development (risk factors) or support that 
development (protective factors). Recent advances in 
functional brain imaging dramatically demonstrate 
the physical changes underlying child development, 
including the relationship between environmental fac-
tors and brain development, and suggest there may 
be particularly sensitive times for the attainment and 
optimization of skills,7 and times when adverse experi-
ences have particularly detrimental effects on brain 
architecture.8 While secure parent–child attachment 
is associated with lifelong mental health, adverse 
child experiences may have severe, lifelong negative 
impacts.9 Thus, the outcomes that preventive health is 
trying to affect are ever-changing, more amenable to 
change at different stages of development, affected by 
both the child’s genetic predispositions and acquired 
experience, and are often not fully realized until much 
later in life. In order to make a shorter-term assess-
ment, there is increasing acceptance of using risk and 
protective factors as primary outcome measures.
The potential range of external factors affect-
ing children’s outcomes is enormous; they vary in 
terms of type, source, intensity, and timing. According 
to Bronfenbrenner’s Ecological Model of Human 
Development,10 children grow in the context of family, 
school and community, and the larger society. Early 
childhood interventions typically focus on family or 
require its active participation. These interventions 
sometimes involve other community members or agen-
cies (e.g., Head Start11) as well. As children develop, 
the target of health interventions moves increasingly 
from the family toward the patient (e.g., HIV/STD pre-
vention12), and the involved community is more often 
peers rather than service providers.
The two key aspects of children’s health and 
well-being—developmental trajectories and social 
ecology—can be used to frame the relationship 
between desired outcomes and selected interventions. 
Many interventions will have multiple outcomes, 
which may vary in both their ecological and their 
developmental dimensions. Different study designs 
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may be required to sensitively address different 
outcomes.
Exhibit 4 illustrates the interplay of these out-
come dimensions. The rows relate to the primary intent 
of the intervention as it tracks to the child’s develop-
mental trajectory. That trajectory may be influenced 
by the presence of: 1) functional or biologic deficits; 
2) risk factors; and/or 3) protective factors. Thus, 
interventions may be categorized as those that aim to 
reduce existing deficits; those that seek to reduce or 
modify risk factors; and those that increase protective 
factors.
The columns correspond to the major categories 
of influences that are part of the child’s social environ-
ment. Some health promotion strategies focus primar-
ily on the individual child; others target the family sys-
tem or are intended to engage or alter larger systems, 
and involve community organizations and agencies or 
public policy. Comprehensive programs often intervene 
at multiple levels. Our framework provides a useful 
way to think about the various elements involved in 
preventive interventions. Exhibit 5 presents that frame-
work we developed using some examples of existing 
interventions; all of these interventions are designed to 
help prepare children to succeed in school.
Methodological implications
The framework also provides guidance on when using 
RCTs to develop guidelines is likely to be more appro-
priate. Randomized controlled trials are designed, opti-
mally, to measure interventions that focus on the indi-
vidual and have the primary intent of mitigating a defi-
cit (Exhibit 5, upper-left box). However, as we move 
away from this category, the suitability and feasibility 
of using an RCT to investigate the relationship between 
an intervention and an outcome tends to decline. Other 
methodological approaches, such as naturalistic obser-
vations, quasi-experiments, and program evaluation,13 
become more practical and useful. 
Health promotion interventions sometimes begin 
by screening populations of children in order to catego-
rize individual children as being either unaffected, at 
risk for, or manifesting evidence of a health condition. 
In the public health model, interventions are described 
as universal (designed to address all children regardless 
of screening status), selective (targeting children at risk 
for a health problem), or indicated (applied to children 
Exhibit 4. The Evidence for Practice (E4P) Framework for Evaluation of  
Health Promotion Activities in the Clinical Setting
Level of Intervention
(the social ecology dimension)
Individual Family
Systems/
Community
In
te
rv
en
tio
na
l I
nt
en
t
(th
e 
de
ve
lo
pm
en
ta
l 
di
m
en
si
on
)
Deficit
Mitigation 1 4 7
Risk Reduction/
Asset Promotion 2 5 8
Health Promotion/
Optimization 3 6 9
Note: Child health promotion occurs in the context of the family and community. Medical therapy is predominantly focused on deficit mitigation;  
health promotion may be directed at optimizing a child’s potential.  These categories have methodological implications (see text). 
Source: Authors’ presentation at Pediatric Academic Societies meeting, 2009.
RCTs
Population-
based, epidemiologic 
studies
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evidence with the inevitable remaining uncertainty 
about questions that research has not and often will not 
address. Whether they are recommending national pol-
icy or considering the care or an individual child, as a 
practical matter, decision-makers must weigh the need 
for the intervention, the chance that it will succeed, and 
the expected, broadly defined risks, costs, and benefits 
of implementation. Generally, the greater the cost and 
the unanswered questions about an intervention, the 
more stringent will be the standards of evidence that 
are applied to making a recommendation. Alternatively, 
the lower the risk and cost and the greater the potential 
gain from the intervention, the less rigorous may be the 
research on which the decision is based. While some 
of these calculations take into account the priorities of 
the health care system, including the provider’s and the 
patient’s priorities, research studies provide estimates 
of overall risk and benefit, which may be included in 
drawing evidence-based conclusions. 
The project participants felt that applying deci-
sion-analysis techniques could be helpful in weighing 
identified as having a condition). These categories 
coincide with traditional categories of preventive care: 
primary, secondary and tertiary. Protocols that involve 
screening will likely employ intervention strategies 
that vary according to the results of the screen. Thus, 
the choice of an appropriate study design to evalu-
ate those interventions would also depend on those 
screening results. This distinction becomes especially 
important when evaluating evidence in order to make 
recommendations for individual care, as opposed to 
making recommendations for populations. The box on 
page 8 analyzes the example of lead screening. In this 
example, different frames of reference resulted in dif-
fering recommendations for practice. 
tHE quEstiOn Of CErtAinty: Linking 
MEtHOds tO rECOMMEndAtiOns
Most recommendations for clinical practice interven-
tions rely only partially on the quality and quantity of 
evidence. Practice recommendations require balanc-
ing what can be concluded by reviewing available 
Exhibit 5. Framework for Categorizing Intervention Programs and Outcomes:  
The Evidence for Practice (E4P) Matrix
Level of Intervention
(the social ecology dimension)
Individual Family Systems/Community
In
te
rv
en
tio
na
l I
nt
en
t
(th
e 
de
ve
lo
pm
en
ta
l d
im
en
si
on
)
Deficit Mitigation Hearing, vision, 
cognitive screening
Adult literacy 
promotion
Immunization 
programs
Risk Reduction “Give a Child  a Book”
Literacy-oriented 
family environment HeadStart
Health Promotion Reach Out & Read Reach Out & Read
Population-based,
epidemiologic 
studies
schools, libraries
Source: Authors’ presentation at Pediatric Academic Societies meeting, 2009.
RCTs
Population-
based, 
epidemiologic 
studies
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the various factors that should be considered in mak-
ing a recommendation for clinical care. Clinical policy 
recommendations, for example, are usually based on 
studies that compare proposed activities with the status 
quo, and only recommend change when there is a high 
likelihood that the new approach is superior. The deci-
sion-analytic framework does not put the status quo in 
this privileged position; new approaches that have a 
higher probability of success than current practice may 
be recommended.
Central to decision analysis is the issue of deter-
mining how much evidence is sufficient to recommend 
an intervention. The approach offers a systematic, 
transparent, and quantitative method for developing 
recommendations. It examines the costs and benefits 
of alternative actions, as well as the likelihood of both 
intended and adverse outcomes.14 This approach has 
major advantages in transparency, and can simultane-
ously evaluate and compare quite different interven-
tions directed at similar outcomes. Decision analysis 
also highlights those areas where uncertainty may 
exist, and allows for analyses of the effects of this 
uncertainty on the final, recommended approach.15 
Further, by making explicit the instances where deci-
sion-makers disagree, or where weights change for 
different populations or over time, the implications of 
those recommendations are assessed directly.16
the next step: Assessing research 
quality and validity
Although RCTs have long been known as the gold 
standard of scientific research, other study designs 
often prove more useful and are finding increasing 
acceptance in published literature. This is especially 
true when researchers are selecting a study design to 
test the effectiveness of a public health intervention. 
As described earlier, child health promotion strategies 
have certain characteristics that suggest, and in some 
cases require, the use of designs other than RCTs. For 
example, newer statistical techniques allow for greater 
use of observational studies and data. Propensity scores 
may be used to account for differences between treat-
ment and control groups in situations where random-
ization is difficult or impossible.17 The Centers for 
Example: Lead Screening
There is little disagreement that lead is toxic to developing brains and that reducing the burden of childhood lead 
toxicity is beneficial. The Centers for Disease Control and Prevention, using traditional epidemiologic methods, 
has consistently recommended screening children for lead at intervals throughout childhood.i This type of 
intervention has resulted in substantial declines in overall childhood lead burden.ii The Interventional Intent would 
be “risk factor reduction” (reducing blood lead levels), and the outcome is measured at the “community” level.
The USPSTF asks a different question and arrives at to a different conclusion. Using their analytic framework, 
screening should be performed when there is therapy that will address the deficit or risk in the individual patient 
who screens positive. Their research determined that there were no published studies linking interventions to 
“improving neurodevelopmental outcomes in children with mild to moderately elevated blood lead levels.”iii The 
USPSTF, therefore, found insufficient evidence to support lead screening as a method of addressing individual 
patient deficits.
Both of these recommendations are evidence-based; they simply addressed different issues and considered 
different evidence. Understood in this way, using the E4P (Evidence for Prevention) matrix as a guide, policymakers 
may consider evidence obtained through a variety of rigorous designs, not only RCTs, and make sound decisions 
regarding policy decisions.iv
i “Recommendations for Blood Lead Screening of Young Children Enrolled in Medicaid: Targeting a Group at High Risk,” Recommendations and Reports: 
Morbidity and Mortality Weekly Report, Dec. 8, 2000 49(RR-14):1–13.
ii “Trends in Blood Lead Levels Among Children—Boston, Massachusetts, 1994–1999,” Morbidity and Mortality Weekly Report, May 4, 2001 50(17):337–39.
iii “Trends in Blood Lead Levels Among Children—Boston, Massachusetts, 1994–1999,” Journal of the American Medical Association, May 23–30, 2001 
285(20):2575–76.
iv R. N. Shiffman, E. K. Marcuse, V. A. Moyer et al., “Toward Transparent Clinical Policies,” Pediatrics, March 2008 121(3):643–46.
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Disease Control and Prevention’s Community Services 
Task Force maintains that the use of “before” and 
“after” trials with concurrent comparison groups, often 
termed “focal-local comparisons” offer strong evidence 
of effectiveness. Finally, Berwick has called for the 
use of quality improvement methodologies in studying 
effective health care improvements.18 These methods, 
drawn from manufacturing practices, have been suc-
cessfully implemented in the child health promotion 
arena.19 
In general, these alternative study designs 
seek to address the difficulties inherent in mov-
ing from well-conducted RCTs that tend to occur 
in tightly controlled experimental situations, to cir-
cumstances and populations more typical of clinical 
practice. Frameworks such as the RE-AIM model20 
(Reach, Effectiveness, Adoption, Implementation, and 
Maintenance) are able to evaluate the applicability—
the external validity—of studies regardless of design. 
These frameworks facilitate the inclusion of epidemio-
logical and other study designs in the evidence base on 
which everyday practice decisions are made (Exhibit 
6). Explicitly assessing both the statistical design and 
the internal validity of a study, as well as its broader 
applicability, can replace the use of RCT study design 
as a proxy indicator of quality and validity.
suMMAry And rECOMMEndAtiOns
Based on this work, we concluded that:
Evidence-based standards favoring RCTs intro-•	
duce hidden biases into policy formation;
High-quality, useful research needs to optimize •	
the conduct of the study itself, and include a  
thorough examination of the applicability out-
side the research environment; and
The level of certainty needed to make recom-•	
mendations for practice should vary in accor-
dance with the likely risks, costs, and potential 
benefits.
These results have contributed to a wide discus-
sion throughout pediatrics. In fact, these results have 
been presented and discussed at national meetings of 
health services researchers since 2006, at Academic 
Pediatric Association Meetings between 2007 and 
2009, and at general national meetings of the American 
Academy of Pediatrics since 2007. 
Focusing on shifting the methods by which evi-
dence is understood is particularly appropriate for this 
moment in the history of American child health care: 
Health care reform and related methods of cost con-
tainment are being hotly debated; pediatrics is focused 
on interventions that maximize children’s development 
and promote their health and well-being not only dur-
ing childhood but also over the course of children’s 
lives. In this context, it is important to reexamine the 
Exhibit 6. RE-AIM Framework
Definition Ecological Level
Reach Participation rate; representativeness of participants Individual
Effectiveness Impact on health outcomes Individual
Adoption Participation rate; representativeness of settings Organizational
Implementation Consistency of delivery of intervention Organizational
Maintenance Individual: long-term effectiveness
Organizational: sustainability
Individual and Organizational
Source: R. E. Glasgow, T. M. Vogt, and S. M. Boles, “Evaluating the Public Health Impact of Health Promotion Interventions: The RE-AIM Framework,” American Journal of 
Public Health, Sept. 1999 89(9):1322–27.
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standards of evidence that are used to determine effec-
tiveness. Continued improvement of these methods is 
necessary to ensure that valuable services are included 
in the health care of American children. 
Building upon a considerable literature con-
cerning medical decision-making, practice-standard 
setting, and policymaking, as well as on input from 
a group of well-informed stakeholders, the Evidence 
for Prevention Project has found that the traditional 
reliance on randomized controlled trials to make pre-
ventive care recommendations systematically ignores 
important evidence. This reliance on RCTs thereby 
deprives practitioners of authoritative support for valu-
able clinical services. Study design should not be seen 
as a proxy for study quality. Well-designed studies 
employ a variety of methods designed to reduce bias 
and attain meaningful results. Moreover, the type and 
quality of evidence sufficient to recommend a particu-
lar intervention should depend on the intervention and 
its outcomes: low-risk, low-cost interventions do not 
require the same level of evidence as equally effica-
cious interventions of higher risk or cost. 
Finally, in evaluating the relationship between 
evidence and the generation of guidelines, we make the 
following recommendations:
Policymakers should not rely solely on recom-1. 
mendations made using current USPSTF meth-
ods when determining covered preventative 
services for children: In practice, the USPSTF 
overwhelmingly relies on RCTs. Efficient 
study designs vary according to the character-
istics of the intervention under consideration. 
Policymakers should consider the cost, risk, 2. 
and potential benefits of an intervention in 
assessing when there is sufficient evidence to 
make a recommendation. In general, low-cost, 
low-risk interventions may be justified even 
when the evidence is less solid; higher-cost/
higher-risk interventions require stronger 
evidence.
Funding for child health research should be 3. 
designed to better balance the need for inter-
nal validity with the need for results that can 
be generalized to typical clinical situations. 
Funding should be directed to those proposals 
that utilize the most efficient and appropriate 
research design for the intended outcomes. The 
process for awarding research funding should 
not use study design (e.g., RCT) as a proxy for 
study quality.
Peer-reviewed journals that act as gatekeep-4. 
ers for the dissemination of child health care 
research findings should encourage investiga-
tors to report on the external validity of their 
intervention research, just as they now require 
standardized reports of parameters associated 
with internal validity.
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